Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Ross, Deborah K. [D-NC-2]

Rep. Ross, Deborah K. [D-NC-2]

United States · Official source

Records

1,949 records where Rep. Ross, Deborah K. [D-NC-2] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 8981 (119th)reported

SCALE Biology Act

United States · United States Congress · 21 May 2026

Bill· HRH.R. 8994 (119th)referred

Protect Working Musicians Act of 2026

United States · United States Congress · 21 May 2026

Protect Working Musicians Act of 202 6 This bill allows certain individual music creator owners to collectively negotiate music licensing terms with dominant online music distribution platforms or companies engaged in development or deployment of generative artificial intelligence, including the right to collectively refuse to license their music to such platforms or companies. Individual music creator owners include musicians, producers, and technicians who own the copyright to a recording and either (1) earned less than $1 million in associated revenues during the prior year, or (2) qualify as a record production and distribution small business. Dominant online music distribution platforms include interactive online services with annual revenues from music distribution of more than $100 million. Generative artificial intelligence includes artificial intelligence systems that are capable of producing novel text, video, images, audio, and other media based on prompts or other forms of inputted data.

Bill· HRH.R. 8811 (119th)referred

Moms Matter Act

United States · United States Congress · 14 May 2026

Resolution· HRESH.Res. 1285 (119th)referred

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

United States · United States Congress · 14 May 2026

Bill· HRH.R. 8744 (119th)referred

TREE Act

United States · United States Congress · 12 May 2026

Bill· HRH.R. 8627 (119th)referred

Petfax Act of 2026

United States · United States Congress · 30 April 2026

Resolution· HRESH.Res. 1243 (119th)referred

Recognizing the significance of Asian American, Native Hawaiian, and Pacific Islander Heritage Month as an important time to celebrate the significant contributions of Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States.

United States · United States Congress · 30 April 2026

This resolution recognizes the significance of Asian American, Native Hawaiian, and Pacific Islander Heritage Month as an important time to celebrate the significant contributions of Asian Americans, Native Hawaiians, and Pacific Islanders to the history of the United States.

Resolution· HRESH.Res. 1212 (119th)referred

Expressing support for the staff of public, school, academic, and special libraries in the United States and the essential services those libraries provide to communities, recognizing the need for funding commensurate with the broad scope of social service and community supports provided by libraries, preserving the right of all citizens of the United States to freely access information and resources in their communities, supporting a strong union voice for library workers, and defending the civil rights of library staff.

United States · United States Congress · 23 April 2026

Bill· HRH.R. 8386 (119th)referred

RECOVER Act of 2026

United States · United States Congress · 20 April 2026

Bill· HRH.R. 8352 (119th)referred

Criminal History Access Act of 2026

United States · United States Congress · 16 April 2026

Criminal History Access Act of 2026 This bill authorizes a new type of entity—peace officer standards and training agencies—to access criminal history record information maintained by the Federal Bureau of Investigation. The term peace officer standards and training agency means an agency of a state, the District of Columbia, or a U.S. territory that is authorized to set standards for the hiring, training, ethical conduct, and retention of its law enforcement officers through certification, licensing, or other similar qualification processes. 

Resolution· HRESH.Res. 1186 (119th)referred

Expressing the sense of the House of Representatives that President Donald Trump, his Special Envoy Steven Witkoff, and all Federal officials must comply with the Foreign Emoluments Clause of the Constitution by immediately turning over to the Department of the Treasury any payments received from the United Arab Emirates or any other foreign state and divest from all business interests linked to foreign governments.

United States · United States Congress · 16 April 2026

Bill· HRH.R. 8317 (119th)referred

Tech to Save Moms Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.